With prolonged exposure or high doses, it transitions to a Phase II block, involving both pre- and post-synaptic effects, including impaired acetylcholine release (autoreceptor inhibition) and open-channel block
It is not currently FDA-approved for all medical uses, which means outcomes can vary between individuals
It provides deep hydration, improves elasticity, and creates a cushioning effect that restores comfort and smooth movement
Key Takeaways Gut lining repair is one of BPC-157s strongest applications, with patients reporting meaningful improvement in GI symptoms within the first 30 days, particularly those with SIBO residuals or NSAID-induced gastritis
Patients should report any unexpected bleeding immediately
Studies examine GLP-1s potential role in: Results may vary